INESSS, QUEBEC’S COST EFFECTIVENESS REVIEW BODY, RELEASED A POSITIVE RECOMMENDATION TO FUND TRIKAFTA 6+
Cystic Fibrosis Canada is calling on Quebec Health Minister to fund Trikafta now.
Read MoreNews
All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.
NIHB AND NORTHWEST TERRITORIES EXPAND ACCESS TO TRIKAFTA, ENSURES LIFE CHANGING DRUG IS ACCESSIBLE TO THOSE WHO NEED IT
TORONTO, August 3, 2022 – The Northwest Territories and Non-Insured Health Benefits (NIHB) have completed an agreement with the manufacturer of Trikafta to fund the revolutionary cystic fibrosis (CF) drug for people aged six years and older, effective July 29, 2022.
Read MoreNOVA SCOTIA EXPANDS ACCESS TO TRIKAFTA, ENSURES LIFE CHANGING DRUG IS ACCESSIBLE TO THOSE WHO NEED IT
Cystic Fibrosis Canada calls on remaining provinces and territories to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreSASKATCHEWAN TO EXPAND ACCESS TO LIFE-CHANGING DRUG TRIKAFTA TO YOUNG CHILDREN
All other provinces and territories called on to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreCYSTIC FIBROSIS CANADA APPLAUDS ALBERTA FOR EXPANDING ACCESS TO LIFE-CHANGING DRUG TRIKAFTA FOR YOUNG CHILDREN
All other provinces and territories called on to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreONTARIO BECOMES FIRST PROVINCE TO EXPAND ACCESS TO LIFE-CHANGING DRUG TRIKAFTA FOR YOUNG CHILDREN AND REMOVES RESTRICTIVE START CRITERIA
All other provinces and territories called on to fund Trikafta for children six and up and lift any overly-restrictive access criteria
Read MoreCYSTIC FIBROSIS CANADA CALLS ON PROVINCES AND TERRITORIES TO IMMEDIATELY FUND TRIKAFTA FOR ALL ELIGIBLE CANADIANS
Review body issues milestone recommendation for the life-changing drug, removes restrictive start criterion
Read MoreCADTH paves way for many Canadian children and adults with cystic fibrosis to access life changing drug - Trikafta
Cystic Fibrosis Canada calls on public and private payers to immediately fund Trikafta for all who can benefit.
Read MoreCystic Fibrosis Canada Commits over $2.1M in New Research Funding
Six Research Grants, an Early Career Investigator Award and three Research Fellowships focus on CF Community’s Health Needs
Read More2021-2022 Impact Report
Read More